Delivery Order SPE2DB20D3101-SPE2DB24FRWB8
Award Date
9/24/24
Potential Completion Date
10/16/24
Potential Value
$58K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 200-unit vials of BOTOX to the Defense Logistics Agency (DLA), a defense agency. The $41,029.92 firm fixed-price delivery order contract has a completion date of July 16, 2025 and was awarded on June 24, 2025. The contract is not set aside for any specific business designation. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of Amerisourcebergen's...
This federal contract award is for the delivery of 200-unit vials of BOTOX to the Defense Logistics Agency (DLA), a defense agency. The $10,257.48 firm-fixed-price delivery order contract was awarded on June 17, 2025 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a completion date of July 10, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of BOTOX 200 unit vials to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $11,642.60, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, with an ultimate completion date of December 4, 2024. The contract was not set aside for any specific business category....
This federal contract award is for the delivery of 200-unit vials of the pharmaceutical drug BOTOX to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for a firm fixed price of $34,927.80. The contract has a completion date of May 24, 2024 and was awarded on May 3, 2024. Amerisourcebergen Drug Corp is the prime contractor and a subsidiary of Cencora, Inc. This contract is a delivery order...
This federal contract award is for the delivery of 200-unit vials of Botox to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a large pharmaceutical distribution company, with a ceiling value of $6,985.56. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC...
This federal contract award is for the delivery of 200-unit vials of Botox to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $11,642.60, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of August 5, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of 200-unit vials of BOTOX to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense (DoD). The contract has a ceiling value of $61,123.65 and a completion date of May 9, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a single-award IDC with the DLA Troop Support Medical...
This federal contract award is for the delivery of 200-unit vials of BOTOX to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on a firm fixed-price basis with a ceiling value of $11,642.60. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which has a maximum value of $999,999,999.00 and...
The federal contract award is for the delivery of BOTOX 200 unit vials to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $63,236.25 and an ultimate completion date of January 7, 2025. The contract was awarded on December 13, 2024 and was not set aside for any specific business type. Amerisourcebergen Drug...
This federal contract award is for the delivery of 200-unit vials of the pharmaceutical product BOTOX to the Defense Logistics Agency (DLA). The $13,971.12 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, on July 31, 2024, with an ultimate completion date of August 21, 2024. The contract is not designated as a set-aside. Amerisourcebergen has been awarded numerous Indefinite Delivery Contracts (IDCs) by...